Reference health

Long-Term Prognosis Factors in Patients with ANCA-Associated Vasculitis

https://doi.org/10.2139/ssrn.4046666
CiteStamped reference-health badge
32/32 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

17 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 32 checked references that resolve
resolves10.7861/clinmedicine.17-1-60
ANCA-associated vasculitis
resolves10.1007/s40620-019-00628-9
Update on ANCA-associated vasculitis: from biomarkers to therapy
resolves10.1093/ndt/gfv022
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
resolves10.2215/CJN.01461005
Incidence of ANCA-Associated Primary Renal Vasculitis in the Miyazaki Prefecture
resolves10.1136/annrheumdis-2013-203927
Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
resolves10.1093/ndt/gfs428
Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study
resolves10.1016/j.semarthrit.2021.02.002
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry
resolves10.1136/ard.2010.137778
Long-term patient survival in ANCA-associated vasculitis
resolves10.1016/j.jaut.2019.102338
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor
resolves10.1007/s11255-016-1419-4
Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist’s perspective
resolves10.1111/1756-185X.13422
Antineutrophilic cytoplasmic antibody‐associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not
resolves10.1016/j.nefroe.2021.07.005
The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
resolves10.1007/s10238-020-00629-0
The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis
resolves10.1080/0886022X.2016.1259633
Predictive value of neutrophil/lymphocyte ratio in renal prognosis of patients with granulomatosis with polyangiitis
resolves10.1007/s00296-018-4125-y
Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study
resolves10.2215/CJN.07300712
Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
resolves10.1007/s10067-015-2882-5
Liver involvement in ANCA-associated vasculitis
resolves10.1007/s00296-020-04704-3
Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
resolves10.1159/000180580
Prediction of Creatinine Clearance from Serum Creatinine
resolves10.1136/ard.2005.051078
Development of comprehensive disease assessment in systemic vasculitis
resolves10.1111/j.1756-185X.2011.01668.x
Serum levels of anti‐streptolysin O antibodies: their role in evaluating rheumatic diseases
resolves10.1007/s10067-008-0844-x
Clinical manifestations associated with high titer of anti-streptolysin O in Behcet’s disease
resolves10.4049/jimmunol.137.7.2173
Detection of C-reactive protein, streptolysin O, and anti-streptolysin O antibodies in immune complexes isolated from the sera of patients with acute rheumatic fever.
resolves10.1016/j.ijporl.2016.08.004
Prevalence of rheumatic heart disease in patients with recurrent tonsillitis and elevated anti-streptolysin O titers
resolves10.1002/art.1780251101
The 1982 revised criteria for the classification of systemic lupus erythematosus
resolves10.1093/rheumatology/40.12.1422
The predictive value of ANA and anti-dsDNA antibodies for flares in SLE
resolves10.1002/art.40930
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
resolves10.1111/cei.12296
Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks
resolves10.1007/BF01409982
Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides
resolves10.1186/s12882-017-0754-8
Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study
resolves10.1134/S0006297918120155
Alternate and Additional Functions of Erythrocyte Hemoglobin
resolves10.1007/978-3-030-41769-7_14
Hemoglobin: Structure, Function and Allostery
The 17 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref2
no DOI — not checkedref14
no DOI — not checkedNeutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study
no DOI — not checkedThe clinical-diagnostic role of antistreptolysin O antibodies
no DOI — not checkedAnti-streptolysin O titer, fifty-five years after Todd: a reappraisal of its clinical significance
no DOI — not checkedA micromethod for the serodiagnosis of rheumatic fever; anti-streptolysin-O test
no DOI — not checkedSystemic lupus erythematosus: a clinical analysis
no DOI — not checkedref34
no DOI — not checkedLymphopenia at diagnosis of ANCA-vasculitis with renal involvement is correlated with severity and renal prognosis
no DOI — not checkedHypoalbuminaemia in antineutrophil cytoplasmic antibodyassociated vasculitis: incidence and significance
no DOI — not checkedref44
no DOI — not checkedref45
no DOI — not checkedref46
no DOI — not checkedref47
no DOI — not checkedAbbreviations: AAV, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
no DOI — not checkedGPA, granulomatosis with polyangiitis; ELISA, enzyme linked immunosorbent assay; MPO, myeloperoxidase; PR3, proteinase 3; IIF, indirect immunofluorescence; c-ANCA, cytoplasm-ANCA; p-ANCA, peripheral-ANCA; ANA, antinuclear antibody; ASO, anti-streptolysin O; GFR, glomerular filtration rate; NLR, neutrophil-to-lymphocyte ratio
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4046666"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4046666/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4046666/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4046666)